We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
-16.22%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.33B
AUM Growth
-$303M
Cap. Flow
-$2.32M
Cap. Flow %
-0.17%
Top 10 Hldgs %
36.19%
Holding
237
New
8
Increased
84
Reduced
90
Closed
19

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$4.42M
2
MDT icon
Medtronic
MDT
+$1.99M
3
PG icon
Procter & Gamble
PG
+$1.78M
4
ROK icon
Rockwell Automation
ROK
+$1.64M
5
APTV icon
Aptiv
APTV
+$1.33M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.71M
2
PYPL icon
PayPal
PYPL
+$5.72M
3
UL icon
Unilever
UL
+$3.05M
4
AMZN icon
Amazon
AMZN
+$1.36M
5
PACB icon
Pacific Biosciences
PACB
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 26.75%
2 Technology 22.62%
3 Industrials 13.8%
4 Communication Services 10.76%
5 Consumer Discretionary 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEE icon
51
NextEra Energy
NEE
$179B
$4.39M 0.33%
56,699
+519
+0.9% +$39.5K
LLY icon
52
Eli Lilly
LLY
$1.09T
$4.14M 0.31%
12,755
+1,018
+9% +$306K
MRK icon
53
Merck
MRK
$329B
$4.13M 0.31%
45,299
-1,923
-4% -$170K
CHD icon
54
Church & Dwight Co
CHD
$24.2B
$4M 0.3%
43,116
– –
MCD icon
55
McDonald's
MCD
$195B
$3.94M 0.3%
15,965
-340
-2% -$83.7K
UNP icon
56
Union Pacific
UNP
$174B
$3.62M 0.27%
16,969
-345
-2% -$78.5K
BRK.B icon
57
Berkshire Hathaway Class B
BRK.B
$1.09T
$3.58M 0.27%
13,101
-1,007
-7% -$316K
FISV
58
Fiserv Inc
FISV
$27.1B
$3.54M 0.27%
39,754
-40
-0.1% -$3.88K
SPY icon
59
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$2.85M 0.21%
7,558
+1,619
+27% +$663K
AMAL icon
60
Amalgamated Financial
AMAL
$1.52B
$2.63M 0.2%
133,158
+6,350
+5% +$123K
BEAM icon
61
Beam Therapeutics
BEAM
$2.78B
$2.63M 0.2%
67,875
-15,389
-18% -$612K
VZ icon
62
Verizon
VZ
$195B
$2.58M 0.19%
50,795
+2,431
+5% +$123K
IBM icon
63
IBM
IBM
$220B
$2.51M 0.19%
17,786
+7,823
+79% +$1.06M
ORCL icon
64
Oracle
ORCL
$432B
$2.11M 0.16%
30,209
-153
-0.5% -$11.2K
BMY icon
65
Bristol-Myers Squibb
BMY
$130B
$2.07M 0.16%
26,860
+4,346
+19% +$331K
MRNA icon
66
Moderna
MRNA
$25.5B
$2.06M 0.15%
14,449
+351
+2% +$50.2K
DXCM icon
67
DexCom
DXCM
$33.8B
$1.97M 0.15%
26,388
-80
-0.3% -$7.3K
ORA icon
68
Ormat Technologies
ORA
$7.1B
$1.97M 0.15%
25,082
-1,720
-6% -$136K
HON icon
69
Honeywell
HON
$73.4B
$1.95M 0.15%
11,897
+2,785
+31% +$500K
MMM icon
70
3M
MMM
$94.5B
$1.91M 0.14%
17,622
-1,178
-6% -$142K
DSGX icon
71
Descartes Systems
DSGX
$6.59B
$1.85M 0.14%
29,795
+6,005
+25% +$375K
NSC icon
72
Norfolk Southern
NSC
$75.1B
$1.85M 0.14%
8,129
-10
-0.1% -$2.46K
AMGN icon
73
Amgen
AMGN
$226B
$1.78M 0.13%
7,338
+2
+0% +$490
PFE icon
74
Pfizer
PFE
$150B
$1.75M 0.13%
33,473
-3,653
-10% -$186K
VUG icon
75
Vanguard Morningstar Growth ETF
VUG
$229B
$1.74M 0.13%
46,812
+2,214
+5% +$91K
1 2
3
4 5

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return

Reynders McVeigh Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Reynders McVeigh Capital Management held 237 positions worth $1.33B, down 19% from $1.64B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Reynders McVeigh Capital Management's Q2 2022 filing shows 8 new, 84 increased, 90 reduced and 19 closed positions. Its largest new stake was Aptiv: 13,046 shares worth $1.16M. The largest sale was Apple, an estimated $9.71M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q2 2022 buy was Aptiv: 13,046 shares worth $1.16M.
  • Reynders McVeigh Capital Management added most to Teradyne in Q2 2022, an estimated $4.42M increase.
  • Reynders McVeigh Capital Management's biggest Q2 2022 reduction was Apple, cutting an estimated $9.71M.
  • Reynders McVeigh Capital Management fully exited Pacific Biosciences in Q2 2022, selling an estimated $1.03M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.33B portfolio in Q2 2022.
  • Reynders McVeigh Capital Management opened 8 new positions and closed 19 in Q2 2022.
  • Reynders McVeigh Capital Management's portfolio value fell 19% quarter-over-quarter to $1.33B.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.